低风险结直肠腺瘤患者结肠镜监测间隔缩短的相关因素及其对结局的影响
研究纳入2004至2008年前瞻性化学预防试验中1560名有低风险腺瘤的参与者,分析内镜医师推荐3年 vs 5年监测间隔的频率、相关因素及随访结局。38.1%被推荐3年间隔,非裔美国人、亚裔/太平洋岛民、检出2个腺瘤、超过3个锯齿状息肉及肠道准备质量一般或差与推荐3年间隔相关;随访时两组腺瘤、进展期腺瘤及临床显著锯齿状息肉比例无显著差异。
要点
- 38.1%的低风险腺瘤患者被推荐3年而非5年监测间隔。
- 非裔美国人、亚裔/太平洋岛民、检出2个腺瘤、超过3个锯齿状息肉及肠道准备差与推荐3年间隔相关。
- 3年与5年推荐组随访时腺瘤、进展期腺瘤及临床显著锯齿状息肉比例无显著差异。
核心结论
- 内镜医师可能受患者家族史、种族、肠道准备质量或息肉数量或大小影响,常对低风险腺瘤患者推荐3年监测间隔而非指南推荐的5年或更长间隔。
- 随访结肠镜检查时,3年与5年推荐组检出1个及以上腺瘤、进展期腺瘤或锯齿状息肉的比例相似。
- 这些发现支持当前指南推荐在指数结肠镜检查后至少5年对低风险腺瘤患者进行随访检查。
研究设计与样本
- 研究收集2004至2008年前瞻性化学预防试验(维生素D和钙)中1560名45至75岁参与者的数据。
- 参与者均在指数结肠镜检查时检出至少1个腺瘤,并由内镜医师推荐在腺瘤检出后3年或5年进行随访结肠镜检查。
- 本分析仅纳入低风险腺瘤(1-2个小管状腺瘤,小于1厘米)参与者,收集参与者及内镜医师特征以及指数和随访结肠镜检查结果。
主要发现
- 594名受试者(38.1%)被推荐3年监测间隔。
- 与推荐5年监测间隔相比,推荐3年间隔的最显著相关因素包括:非裔美国人种族(相对风险[RR]对白人,1.41;95%置信区间[CI],1.14-1.75)、亚裔/太平洋岛民(RR对白人,1.7;95%CI,1.22-2.43)、指数检查检出2个腺瘤(RR vs 1个腺瘤,1.47;95%CI,1.27-1.71)、指数检查超过3个锯齿状息肉(RR=2.16,95%CI,1.59-2.93)以及指数检查肠道准备质量一般或差(RR vs 极佳质量,2.16;95%CI,1.66-2.83)。
- 其他与推荐3年监测间隔显著相关的因素包括结直肠癌家族史和指数检查检出1-2个锯齿状息肉。
- 随访结肠镜检查时,3年 vs 5年推荐组检出1个及以上腺瘤的比例分别为38.8% vs 41.7%(P = .27),进展期腺瘤分别为7.7% vs 8.2%(P = .73),临床显著锯齿状息肉分别为10.0% vs 10.3%(P = .82),均无显著差异。
关键数值与推荐
- 低风险腺瘤定义为1-2个小管状腺瘤,小于1厘米。
- 3年监测间隔推荐率:594/1560(38.1%)。
- 非裔美国人种族推荐3年 vs 5年的RR为1.41(95%CI,1.14-1.75)。
- 亚裔/太平洋岛民推荐3年 vs 5年的RR为1.7(95%CI,1.22-2.43)。
- 指数检查检出2个腺瘤 vs 1个腺瘤推荐3年间隔的RR为1.47(95%CI,1.27-1.71)。
临床怎么用
- 原文结论支持当前指南推荐在指数结肠镜检查后至少5年对低风险腺瘤患者进行随访检查。
- 原文未据此给出其他临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Endoscopists do not routinely follow guidelines to survey individuals with low-risk adenomas (LRAs; 1-2 small tubular adenomas, < 1 cm) every 5-10 years for colorectal cancer; many recommend shorter surveillance intervals for these individuals. We aimed to identify the reasons that endoscopists recommend shorter surveillance intervals for some individuals with LRAs and determine whether timing affects outcomes at follow-up examinations. METHODS: We collected data from 1560 individuals (45-75 years old) who participated in a prospective chemoprevention trial (of vitamin D and calcium) from 2004 through 2008. Participants in the trial had at least 1 adenoma, detected at their index colonoscopy, and were recommended to receive follow-up colonoscopy examinations at 3 or 5 years after adenoma identification, as recommended by the endoscopist. For this analysis we collected data from only participants with LRAs. These data included characteristics of participants and endoscopists and findings from index and follow-up colonoscopies. Primary endpoints were frequency of recommending shorter (3-year) vs longer (5-year) surveillance intervals, factors associated with these recommendations, and effect on outcome, determined at the follow-up colonoscopy. RESULTS: A 3-year surveillance interval was recommended for 594 of the subjects (38.1%). Factors most significantly associated with recommendation of 3-year vs a 5-year surveillance interval included African American race (relative risk [RR] to white, 1.41; 95% confidence interval [CI], 1.14-1.75), Asian/Pacific Islander ethnicity (RR to white, 1.7; 95% CI, 1.22-2.43), detection of 2 adenomas at the index examination (RR vs 1 adenoma, 1.47; 95% CI, 1.27-1.71), more than 3 serrated polyps at the index examination (RR=2.16, 95% CI, 1.59-2.93), or index examination with fair or poor quality bowel preparation (RR vs excellent quality, 2.16; 95% CI, 1.66-2.83). Other factors that had a significant association with recommendation for a 3-year surveillance interval included family history of colorectal cancer and detection of 1-2 serrated polyps at the index examination. In comparisons of outcomes, we found no significant differences between the 3-year vs 5-year recommendation groups in proportions of subjects found to have 1 or more adenomas (38.8% vs 41.7% respectively; P = .27), advanced adenomas (7.7% vs 8.2%; P = .73) or clinically significant serrated polyps (10.0% vs 10.3%; P = .82) at the follow-up colonoscopy. CONCLUSIONS: Possibly influenced by patients' family history, race, quality of bowel preparation, or number or size of polyps, endoscopists frequently recommend 3-year surveillance intervals instead of guideline-recommended intervals of 5 years or longer for individuals with LRAs. However, at the follow-up colonoscopy, similar proportions of participants have 1 or more adenomas, advanced adenomas, or serrated polyps. These findings support the current guideline recommendations of performing follow-up examinations of individuals with LRAs at least 5 years after the index colonoscopy.
引用
- Anderson JC, Baron JA, Ahnen DJ, et al. Factors Associated With Shorter Colonoscopy Surveillance Intervals for Patients With Low-Risk Colorectal Adenomas and Effects on Outcome. Gastroenterology. 2017. PMID: 28219690. doi:10.1053/j.gastro.2017.02.010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。